Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States
The National Academies will convene a meeting Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States on March 16-19, 2021 via virtual format. During these meetings, expert speakers will discuss GARP’s work developing treatments for drug-resistant infections and CMS reimbursement for new antibiotics. Speakers will also present on the challenges